Biotech · Public company · San Mateo, CA, US
Talphera, Inc.
Ticker TLPH · SEC CIK 0001427925
Track this companyFree. Adds Talphera, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- Niyad (nafamostat mesylate)Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Nafamostat Efficacy in Phase 3 Registrational CRRT StudyNA · UNKNOWN · started Aug 15, 2024ClinicalTrials.gov NCT06150742 · fetched Nov 12, 2026
SEC filings12
- 10-Q · FORM 10-QSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 23, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 10-K · FORM 10-KSEC EDGAR · filed Mar 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 16, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 13, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 24, 2025 · fetched Nov 12, 2026